Spine Tumor
9
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR SPINE ONCOLOGY: A PILOT STUDY
Spine Oncology Registry
Effect of Ketamine on Intraoperative Motor Evoked Potentials
Reasons and Risk Factors for Unplanned Spinal Re-operation
Multi-modality Evaluation of Flow Rate, Pressure and Size of Spine Epidural Venous Plexus
Multimodal Imaging-assisted Diagnosis Model for Cervical Spine Tumors
Comparison of the Effects of Vecuronium and Cisatracurium on Electrophysiologic Monitoring During Neurosurgery
Predictors of Mortality and Morbidity in the Surgical Management of Primary Tumors of the Spine